Exact Mass: 388.0575022
Exact Mass Matches: 388.0575022
Found 248 metabolites which its exact mass value is equals to given mass value 388.0575022,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Na-CPT
Camptothecin Sodium is the sodium salt of camptothecin, an alkaloid isolated from the Chinese tree Camptotheca acuminata, with antineoplastic activity. During the S phase of the cell cycle, camptothecin selectively stabilizes topoisomerase I-DNA covalent complexes, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. The sodium salt of camptothecin is more water-soluble than the parent molecule. (NCI04) Sodium Camptothecin is a plant alkaloid, with antitumor activity. Sodium Camptothecin is a reversible inhibitor of RNA synthesis. Sodium Camptothecin is an effective inhibitor of adenovirus replication. Sodium Camptothecin inhibits DNA synthesis and causes breaks in intracellular preformed viral DNA[1][2].
Betanidin
Minor congener of Betanidin. Isobetanidin is found in root vegetables. Isobetanidin is found in root vegetables. Minor congener of Betanidi
Dopaxanthin quinone
Dopaxanthin quinone is produced by the reaction between dopaxanthin and oxygen, with water as a byproduct. A tyrosinase precursor enzyme catalyzes the reaction. [HMDB] Dopaxanthin quinone is produced by the reaction between dopaxanthin and oxygen, with water as a byproduct. A tyrosinase precursor enzyme catalyzes the reaction.
Penicillin V potassium
C16H17KN2O5S (388.0495212000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Triflupromazine hydrochloride
C18H20ClF3N2S (388.09877460000007)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics
Oxyquinoline sulfate
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
zopiclone
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3643 CONFIDENCE standard compound; INTERNAL_ID 1579
Eszopiclone
Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent (viz., a sedative) used as a treatment for insomnia. Eszopiclone is the active stereoisomer of zopiclone, and belongs to the class of drugs known as cyclopyrrones. Its main selling point is that it is approved by the U.S. Food and Drug Administration for long-term use, unlike almost all other hypnotic sedatives, which are approved only for the relief of short-term (6-8 weeks) insomnia. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
Zopiclone
Zopiclone is only found in individuals that have used or taken this drug. It is a novel hypnotic agent used in the treatment of insomnia. Its mechanism of action is based on modulating benzodiazepine receptors. In addition to zopiclones benzodiazepine pharmacological properties it also has some barbiturate like properties. Zopiclone exerts its action by binding on the benzodiazepine receptor complex and modulation of the GABABZ receptor chloride channel macromolecular complex. Both zopiclone and benzodiazepines act indiscriminately at the benzodiazepine binding site on α1, α2, α3 and α5 GABAA containing receptors as full agonists causing an enhancement of the inhibitory actions of GABA to produce the therapeutic (hypnotic and anxiolytic) and adverse effects of zopiclone. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
Urolithin B 3-O-glucuronide
Urolithin B 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
2-[4-Acetamido-3-(4-chlorophenyl)sulfanyl-2-methylindol-1-yl]acetic acid
C19H17ClN2O3S (388.06483620000006)
[6-(5-Chloropyridin-2-yl)-7-hydroxypyrrolo[3,4-b]pyrazin-5-yl] 4-methylpiperazine-1-carboxylate
2-[(3S,5R)-5-[6-(2,4-Dichlorophenyl)hexyl]-3-hydroxy-2-oxooxolan-3-yl]acetic acid
2-hydroxy-3-butenylglucosinolate
C11H18NO10S2 (388.03721079999997)
2-hydroxy-3-butenylglucosinolate is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. 2-hydroxy-3-butenylglucosinolate is soluble (in water) and an extremely strong acidic compound (based on its pKa). 2-hydroxy-3-butenylglucosinolate can be found in a number of food items such as wax gourd, sweet marjoram, bamboo shoots, and chicory roots, which makes 2-hydroxy-3-butenylglucosinolate a potential biomarker for the consumption of these food products.
5,7,2,5-Tetrahydroxy-3,4-dimethoxyflavone 5-acetate
Betanidin
D004396 - Coloring Agents > D050859 - Betacyanins D004396 - Coloring Agents > D050858 - Betalains
3,5-Dihydroxy-6,7,8-trimethoxy-3,4-methylenedioxyflavone
2-{[2,2,2-trifluoro-1-[(isopropoxycarbonyl)amino]-1-(trifluoromethyl)ethyl]amino}benzoic acid
C14H14F6N2O4 (388.08577160000004)
3,4,6a,12a-Tetrahydro-4a,12b-epoxy-2,3,6a,8,12a-pentahydroxy-3-methylbenz[a]anthracene-1,7,12(2H)-trione
erimopyrone|[1R,2S]-1-(6-carboxy-2-oxo-2H-4-pyranyl)-6,7-dihydroxy-1,2-dihydro-2,3-naphthalenedicarboxylic acid
2-bromo-3-chloro-5-acetoxy-chamigra-7(14),9-dien-8-one|4-bromo-3-chloro-3,7,7-trimethyl-10-oxospiro<5.5>undec-8-en-1-yl acetate|4-bromo-3-chloro-3,7,7-trimethyl-10-oxospiro[5.5]undec-8-en-1-yl acetate
C17H22BrClO3 (388.04407520000007)
Salazinic acid
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates Origin: Microbe, Carboxylic acids
3,6,8-Trimethoxy-5,7-dihydroxy-3,4-methylenedioxyflavone
4,6-Diformyl-3,8-dihydroxy-9-hydroxymethyl-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure|4,6-diformyl-3,8-dihydroxy-9-hydroxymethyl-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid
(+)-4-acetoxymarilzallene
C17H22BrClO3 (388.04407520000007)
A natural product found in Laurencia marilzae.
2,6-Pyridinedicarboxylicacid,4-[2-[(2S)-2-carboxy-2,3-dihydro-5,6-dihydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-,(2S)-
(2S)-2,3-dihydroxypropyl 1,6,8-trihydroxy-3-methylanthraquinone-2-carboxylate
1-(6-carboxy-2-oxopyran-3-yl)-6,7-dihydroxy-1,2-dihydronaphthalene-2,3-dicarboxylic acid
3,3-Methylenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)
1,1,4,4-Tetrahydro-1,1,4,4-tetraoxo-3-hydroxy-2,2-binaphthalene-3-carboxylic acid methyl ester
12A-Hydroxy-9-Demethylmunduserone-8-Carboxylic Acid
Esopiclone
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
Urolithin B 3-O-glucuronide
Pamoic acid
Pamoic acid (Embonic acid) is a potent GPR35 agonist with an EC50 of 79 nM. Pamoic acid exhibits neuroprotective and anti-inflammatory properties[1][2].
3-chloro-2-oxopropyl triphenylphosphonium chloride
Estrone sulfate potassium
C18H21KO5S (388.07467160000004)
Estrone sulfate potassium is a natural endogenous steroid and is an estrogen ester and conjugate[1].
tert-Butyl (3-((2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)carbamate
C16H16ClF3N4O2 (388.09138219999994)
ETHYL 4,6-BIS(4-CHLOROPHENYL)-2-OXO-3-CYCLOHEXENE-1-CARBOXYLATE
2-[(4-chloro-2-nitrophenyl)azo]-N-(2,4-dimethylphenyl)-3-oxobutyramide
2-(4-Boc-piperazinyl)-α-(3,4-dichloro-phenyl)acetic acid
(R)-Zopiclone
dimethyl 4-[2,6-bis(methoxycarbonyl)pyridin-4-yl]pyridine-2,6-dicarboxylate
tert-butyldiphenylsilyl triflate)
C17H19F3O3SSi (388.07762199999996)
2-(2-anilinovinyl)-3-(2-carboxyethyl)benzoxazolium bromide
5-chloro-2-[4-(1,3-dioxolan-2-yl)phenyl]-3-phenyl-1,6-naphthyridine
2-(4-Boc-piperazinyl)-α-(2,4-dichloro-phenyl)acetic acid
tert-Butyl 4-(4-iodophenyl)piperazine-1-carboxylate
2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSYL ISOTHIOCYANATE
2,4,6,8-Tetramethyl-2-(2-(trimethoxysilyl)ethyl)cyclotetrasiloxane
(5R)-5-(Chloromethyl)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl}-1,3-oxazolidin-2-one
1-butyl-2,3-dimethylimidazolium hexafluoroantimonate
diethyl 4,4-dinitro-[1,1-biphenyl]-2,2-dicarboxylate
6,8-Difluoro-4-methyl-2-oxo-2H-1-benzopyran-7-yl beta-D-glucopyranosiduronic acid
5(4H)-Oxazolone,4-[[4-[bis(2-chloroethyl)amino]phenyl]methylene]-2-phenyl-
C20H18Cl2N2O2 (388.07452679999994)
N-Carbobenzyloxy-L-arginine hydrobromide
C14H21BrN4O4 (388.07460860000003)
AZD1981
C19H17ClN2O3S (388.06483620000006)
3-(1h,1h,7h-dodecafluoroheptyloxy)-1,2-epoxypropane
C10H8F12O2 (388.03326519999996)
2-(5-BROMO-2-(2,2,2-TRIFLUOROETHOXY)PHENYL)ADAMANTANE
2-[4-Methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one
2-(6-benzimidazolo[1,2-c]quinazolinylthio)-N-(2-furanylmethyl)acetamide
5-bromo-N-[2-(6,7-dimethyl-2-oxo-1H-quinolin-3-yl)ethyl]-2-furancarboxamide
ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate
5-Bromo-N[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide
Eszopiclone
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
3-[4-(4-Luorophenyl)sulonylpiperazin-1-yl]chromen-4-one
C19H17FN2O4S (388.08930140000007)
2-Methylsulfonylmethyl-3,4,5-triacetoxybenzyl methyl ether
2-[(3S,5R)-5-[6-(2,4-Dichlorophenyl)hexyl]-3-hydroxy-2-oxooxolan-3-yl]acetic acid
(S)-2-hydroxy-3-butenyl glucosinolate
C11H18NO10S2- (388.03721079999997)
(R)-2-hydroxy-but3-enyl-glucosinolate
C11H18NO10S2- (388.03721079999997)
2-Carboxy-1-[(2,6-dicarboxy-2,3-dihydro-4(1H)-pyridinylidene)ethylidene]-2,3-dihydro-5,6-dihydroxy-1H-indolium hydroxide inner salt
(4E)-4-[2-[1-carboxy-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid
2-hydroxy-3-butenylglucosinolate
C11H18NO10S2- (388.03721079999997)
4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide
C17H16N4O3S2 (388.06637859999995)
(2E)-N-({4-[(acetylcarbamothioyl)amino]phenyl}carbamothioyl)-3-(furan-2-yl)prop-2-enamide
C17H16N4O3S2 (388.06637859999995)
6-[(2-methoxyphenyl)methylsulfamoyl]-4-oxo-1H-quinoline-3-carboxylic acid
1-S-[3-hydroxy-N-(sulfonatooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose
C11H18NO10S2- (388.03721079999997)
(-)-4-Acetoxymarilzallene, (rel)-
C17H22BrClO3 (388.04407520000007)
A natural product found in Laurencia marilzae.
N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide
N-(2,1,3-benzothiadiazol-4-yl)-3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamide
N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine;hydron;chloride
C18H20ClF3N2S (388.09877460000007)
N-[2-(4-methoxyphenyl)-1,3-benzoxazol-5-yl]-1,3-benzodioxole-5-carboxamide
N(6)-carbamoylmethyl-2-deoxyadenosine 5-monophosphate
C12H17N6O7P (388.08963020000004)
A nucleoside monophosphate analogue that is dAMP in which one of the exocyclic amino hydrogens is replaced by a carbamoylmethyl group.
N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide
N-[2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)-pyridine-3-carboxamide
1-[(2-Carboxy-3-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid
2-Chloro-5-[(2E)-2-[(5-chloro-3-methyl-1-phenylpyrazol-4-yl)methylidene]hydrazinyl]benzoic acid
C18H14Cl2N4O2 (388.04937639999997)
(R)-2-Hydroxy-3-butenyl glucosinolate
C11H18NO10S2- (388.03721079999997)
4-[5-[(E)-(1-oxo-[1,3]thiazolo[3,2-a]benzimidazol-2-ylidene)methyl]furan-2-yl]benzoic acid
C21H12N2O4S (388.05177520000007)
(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C14H17BrN2O4S (388.00923420000004)
(6R,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C14H17BrN2O4S (388.00923420000004)
(6S,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C14H17BrN2O4S (388.00923420000004)
(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C14H17BrN2O4S (388.00923420000004)
(17S)-5,13,17-Trihydroxy-12-(hydroxymethyl)-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.03,8.014,18]octadeca-1(11),3(8),4,6,12,14(18)-hexaene-4-carbaldehyde
(1R,5S)-6-(4-chlorophenyl)sulfonyl-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane
C20H21ClN2O2S (388.10121960000004)
(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C14H17BrN2O4S (388.00923420000004)
(6S,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C14H17BrN2O4S (388.00923420000004)
(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C14H17BrN2O4S (388.00923420000004)
trans-Cinnamyl methyl 2-tosylmalonate
C20H20O6S (388.09805400000005)
6-[(3-Bromo-4-hydroxy-5-nitrophenyl)acetamido]caproic acid
1-S-[(1Z)-N-(sulfonatooxy)hexanimidoyl]-1-thio-beta-D-glucopyranose
1-S-[(1Z)-3-methyl-N-(sulfonatooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose
1-S-[(3S)-3-hydroxy-N-(sulfonatooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose
C11H18NO10S2- (388.03721079999997)
(Z)-4-(1,3-Benzothiazol-2-yl)-5-(4-chloro-3-nitrophenyl)pent-4-enoic acid
C18H13ClN2O4S (388.0284528000001)
6-[5-(2-Carboxy-2-oxoethyl)-2,3-dihydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[3-(2,4-Dihydroxy-5-methoxyphenyl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[3-(2,4-Dihydroxy-3-methoxyphenyl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[4-(2-Carboxyethyl)-5-hydroxy-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
2-amino-7-[4-hydroxy-5-(phosphonooxymethyl)-2,5-dihydrofuran-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid
xi-progoitrin(1-)
C11H18NO10S2 (388.03721079999997)
A glucosinolate resulting from the removal of a proton from the oxime hydrogen sulfate moiety of xi-progoitrin.
progoitrin(1-)
C11H18NO10S2 (388.03721079999997)
A xi-progoitrin(1-) that is the conjugate base of progoitrin.
epi-progoitrin(1-)
C11H18NO10S2 (388.03721079999997)
A xi-progoitrin(1-) that is the conjugate base of epi-progoitrin.
2-methylbutylglucosinolate
An alkylglucosinolate that is the conjugate base of 2-methylbutylglucosinolic acid.
pentylglucosinolate
An alkylglucosinolate that is the conjugate base of pentylglucosinolic acid.
1-Phosphatidyl-1D-myo-inositol
C11H17O13P (388.04067620000006)
A phosphatidylinositol in which the inositol moiety is the 1D-myo isomer and the phosphatidyl group is located at its position 1.
S6K1-IN-DG2
C16H17BrN6O (388.06471319999997)
S6K1-IN-DG2 (Compound 66) is a p70S6K inhibitor (IC50: < 100 nM)[1].
SB 204990
SB 204990 is a potent and specific inhibitor of ATP citrate lyase (ACLY) enzyme.
(2r,4r,5r,8r)-4-bromo-2-[(3z)-1-chlorohex-3-en-5-yn-1-yl]-8-ethyl-3,4,5,8-tetrahydro-2h-oxocin-5-yl acetate
C17H22BrClO3 (388.04407520000007)
(2r)-2-carboxy-1-{2-[(2r)-2-carboxy-6-carboxylato-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium
(1s,2r,11r,14r,16s,17s)-2,8,11,16,17-pentahydroxy-16-methyl-19-oxapentacyclo[12.4.1.0¹,¹⁴.0²,¹¹.0⁴,⁹]nonadeca-4,6,8,12-tetraene-3,10,18-trione
(1r,3r,4s)-4-bromo-3-chloro-3,7,7-trimethyl-11-methylidene-10-oxospiro[5.5]undec-8-en-1-yl acetate
C17H22BrClO3 (388.04407520000007)
11-chloro-4,9,10,12,12b-pentahydroxy-1,2,10,11,12,12a-hexahydroperylen-3-one
2,8,11,16,17-pentahydroxy-16-methyl-19-oxapentacyclo[12.4.1.0¹,¹⁴.0²,¹¹.0⁴,⁹]nonadeca-4,6,8,12-tetraene-3,10,18-trione
1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid
(1s,3r,4r,6r)-4-bromo-3-chloro-3,7,7-trimethyl-11-methylidene-10-oxospiro[5.5]undec-8-en-1-yl acetate
C17H22BrClO3 (388.04407520000007)
(5e)-5-[(6-bromo-1-propanoylindol-3-yl)methylidene]-2-imino-1,3-dimethylimidazolidin-4-one
C17H17BrN4O2 (388.05348019999997)
(17r)-13,17-dihydroxy-4-(hydroxymethyl)-5-methoxy-7,12-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
5'-benzyl-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol
(2r,3z,5r,6r,8r)-6-bromo-8-[(3z)-1-chlorohex-3-en-5-yn-1-yl]-2-ethyl-5,6,7,8-tetrahydro-2h-oxocin-5-yl acetate
C17H22BrClO3 (388.04407520000007)
(1r,2r)-1-(6-carboxy-2-oxopyran-3-yl)-6,7-dihydroxy-1,2-dihydronaphthalene-2,3-dicarboxylic acid
13,17-dihydroxy-4-(hydroxymethyl)-5-methoxy-7,12-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
2-(5-hydroxy-4-keto-3,7-dimethoxy-chromen-2-yl)-3,5-dimethoxy-p-benzoquinone
{"Ingredient_id": "HBIN004681","Ingredient_name": "2-(5-hydroxy-4-keto-3,7-dimethoxy-chromen-2-yl)-3,5-dimethoxy-p-benzoquinone","Alias": "2-(5-hydroxy-3,7-dimethoxy-4-oxo-chromen-2-yl)-3,5-dimethoxy-cyclohexa-2,5-diene-1,4-dione; 2-(5-hydroxy-3,7-dimethoxy-4-oxo-chromen-2-yl)-3,5-dimethoxy-1,4-benzoquinone; 2-(5-hydroxy-3,7-dimethoxy-4-oxo-2-chromenyl)-3,5-dimethoxy-1,4-benzoquinone; 2-(5-hydroxy-3,7-dimethoxy-4-oxochromen-2-yl)-3,5-dimethoxycyclohexa-2,5-diene-1,4-dione","Ingredient_formula": "C19H16O9","Ingredient_Smile": "NA","Ingredient_weight": "388.32","OB_score": "9.967632099","CAS_id": "149420-75-7","SymMap_id": "SMIT11228","TCMID_id": "NA","TCMSP_id": "MOL010158","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9'-(o-methyl)protocetraricacid
{"Ingredient_id": "HBIN014170","Ingredient_name": "9'-(o-methyl)protocetraricacid","Alias": "NA","Ingredient_formula": "C19H16O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14689","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
βetanidin
{"Ingredient_id": "HBIN018102","Ingredient_name": "\u03b2etanidin","Alias": "NA","Ingredient_formula": "C18H16N2O8","Ingredient_Smile": "C1C(NC(=CC1=CC=[N+]2C(CC3=CC(=C(C=C32)O)O)C(=O)[O-])C(=O)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2320","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
betanidin
{"Ingredient_id": "HBIN018205","Ingredient_name": "betanidin","Alias": "betanidin radical","Ingredient_formula": "C18H16N2O8","Ingredient_Smile": "C1C(N=C(C=C1C=CN2C(CC3=CC(=C(C=C32)O)O)C(=O)O)C(=O)O)C(=O)O","Ingredient_weight": "388.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT18318","TCMID_id": "23207","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137218006","DrugBank_id": "NA"}
(1r,2s)-1-(2-carboxy-6-oxopyran-4-yl)-6,7-dihydroxy-1,2-dihydronaphthalene-2,3-dicarboxylic acid
(1r,15r,23s)-4,9,11,15-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8,10,12(24),16,18,20-nonaen-13-one
(3r,4s,6s)-4-bromo-3-chloro-3,7,7-trimethyl-11-methylidene-10-oxospiro[5.5]undec-8-en-1-yl acetate
C17H22BrClO3 (388.04407520000007)
5,13,17-trihydroxy-7,12-dimethyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-4-carboxylic acid
4-bromo-3-chloro-3,7,7-trimethyl-11-methylidene-10-oxospiro[5.5]undec-8-en-1-yl acetate
C17H22BrClO3 (388.04407520000007)
7'-chloro-4',5,5',6'-tetrahydroxy-2,3,6',7'-tetrahydro-1h,5'h-[1,1'-binaphthalene]-4,8'-dione
(3s,6e)-3-[(2s)-3,3-dichloro-2-methylpropyl]-6-[(2s)-3,3-dichloro-2-methylpropylidene]-1,4-dimethylpiperazine-2,5-dione
C14H20Cl4N2O2 (388.02788200000003)
6,9,11,14-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8(24),9,11,16,18,20-nonaen-13-one
methyl 6-[(acetyloxy)methyl]-8-hydroxy-2-(methylsulfanyl)-9-oxoxanthene-1-carboxylate
15-formyl-14-hydroxy-6,13-dimethoxy-7,12-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-4-carboxylic acid
2-(2h-1,3-benzodioxol-5-yl)-5,7-dihydroxy-3,6,8-trimethoxychromen-4-one
(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid
4,9,11,15-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8,10,12(24),16,18,20-nonaen-13-one
(17s)-4,13-dihydroxy-5,17-dimethoxy-7,12-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
(1r,14r,15s,23s)-6,9,11,14-tetrahydroxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2,4,6,8(24),9,11,16,18,20-nonaen-13-one
8,18-dihydroxy-20-methoxy-6,16-dimethyl-12-oxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-1(13),2(11),4,6,8,14(19),15,17,20-nonaene-3,10-dione
(10s,11r,12r,12br)-11-chloro-4,9,10,12,12b-pentahydroxy-1,2,10,11,12,12a-hexahydroperylen-3-one
2-chloro-7-[(1e)-hex-1-en-1-yl]-1,3,6,8-tetrahydroxyanthracene-9,10-dione
(17r)-13,17-dihydroxy-12-(hydroxymethyl)-5-methoxy-4,7-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
2-chloro-7-(hex-1-en-1-yl)-1,3,6,8-tetrahydroxyanthracene-9,10-dione
(1s)-1-(3-bromo-4-methoxyphenyl)-2-{[2-(1h-indol-3-yl)ethyl]amino}ethanol
(1s,4as,7as)-1-{[(2s,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4,7-dicarboxylic acid
(3s,6z)-3-[(2s)-3,3-dichloro-2-methylpropyl]-6-[(2s)-3,3-dichloro-2-methylpropylidene]-1,4-dimethylpiperazine-2,5-dione
C14H20Cl4N2O2 (388.02788200000003)
(2s)-2,3-dihydroxypropyl 1,6,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylate
(2s)-4-[(1e)-2-[(2r)-2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-yl]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid
methyl 3'-hydroxy-1,1',4,4'-tetraoxo-[2,2'-binaphthalene]-3-carboxylate
(1s,5'r,6'r,7's)-7'-chloro-4',5,5',6'-tetrahydroxy-2,3,6',7'-tetrahydro-1h,5'h-[1,1'-binaphthalene]-4,8'-dione
(2r,5'r,7s,7as)-5'-benzyl-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol
15-formyl-6,14-dihydroxy-7-(methoxymethyl)-4,12-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylic acid
(5z)-3-benzyl-5-[(3,5-dichloro-4-hydroxyphenyl)methylidene]-4-isopropylfuran-2-one
2-(5-hydroxy-3,7-dimethoxy-4-oxochromen-2-yl)-3,5-dimethoxycyclohexa-2,5-diene-1,4-dione
2,3-dihydroxypropyl 1,6,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylate
4,13-dihydroxy-5,17-dimethoxy-7,12-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
3-(3,3-dichloro-2-methylpropyl)-6-(3,3-dichloro-2-methylpropylidene)-1,4-dimethylpiperazine-2,5-dione
C14H20Cl4N2O2 (388.02788200000003)